1. Home
  2. LARK vs CRBU Comparison

LARK vs CRBU Comparison

Compare LARK & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LARK
  • CRBU
  • Stock Information
  • Founded
  • LARK 1885
  • CRBU 2011
  • Country
  • LARK United States
  • CRBU United States
  • Employees
  • LARK N/A
  • CRBU N/A
  • Industry
  • LARK Major Banks
  • CRBU Medicinal Chemicals and Botanical Products
  • Sector
  • LARK Finance
  • CRBU Health Care
  • Exchange
  • LARK Nasdaq
  • CRBU Nasdaq
  • Market Cap
  • LARK 150.1M
  • CRBU 179.7M
  • IPO Year
  • LARK N/A
  • CRBU 2021
  • Fundamental
  • Price
  • LARK $25.92
  • CRBU $2.44
  • Analyst Decision
  • LARK
  • CRBU Strong Buy
  • Analyst Count
  • LARK 0
  • CRBU 3
  • Target Price
  • LARK N/A
  • CRBU $6.67
  • AVG Volume (30 Days)
  • LARK 7.1K
  • CRBU 1.1M
  • Earning Date
  • LARK 10-29-2025
  • CRBU 11-07-2025
  • Dividend Yield
  • LARK 3.24%
  • CRBU N/A
  • EPS Growth
  • LARK 38.73
  • CRBU N/A
  • EPS
  • LARK 2.98
  • CRBU N/A
  • Revenue
  • LARK $64,367,999.00
  • CRBU $9,121,000.00
  • Revenue This Year
  • LARK N/A
  • CRBU $8.06
  • Revenue Next Year
  • LARK N/A
  • CRBU N/A
  • P/E Ratio
  • LARK $8.70
  • CRBU N/A
  • Revenue Growth
  • LARK 12.95
  • CRBU N/A
  • 52 Week Low
  • LARK $19.09
  • CRBU $0.66
  • 52 Week High
  • LARK $31.04
  • CRBU $3.00
  • Technical
  • Relative Strength Index (RSI)
  • LARK 45.63
  • CRBU 45.99
  • Support Level
  • LARK $25.29
  • CRBU $2.35
  • Resistance Level
  • LARK $26.24
  • CRBU $2.59
  • Average True Range (ATR)
  • LARK 0.45
  • CRBU 0.20
  • MACD
  • LARK -0.01
  • CRBU -0.06
  • Stochastic Oscillator
  • LARK 47.73
  • CRBU 2.71

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The Bank has continued to focus on increasing its originations of commercial, commercial real estate (CRE), and agricultural loans, which management believes will be more profitable and provide more growth for the Bank than traditional one-to-four-family residential real estate lending. In addition, it also invests in certain investment and mortgage-related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: